BIOCSL

CSL Limited

Application Filed: 2012-12-21
Trademark Application Details
Trademark Logo BIOCSL
700
Live/Registered
REGISTERED
Research OneLook Acronym Finder
Serial Number79128394
Registration Number4493063
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Domestic RepresentativeFross Zelnick Lehrman & Zissu, P.C.
Attorney NameNancy Sabarra
Attorney Docket NumberCSLL 1912151
Law Office AssignedL80
Employee NameWIENER, MICHAEL A

Timeline

2012-12-21Application Filed
2013-12-24Published for Opposition
2014-03-11Location: PUBLICATION AND ISSUE SECTION
2014-03-11Status: Live/Registered
2014-03-11Trademark Registered
2019-11-25Transaction Date

Trademark Applicants & Owners

Owner: CSL Limited
Address45 Poplar Road PARKVILLE VIC 3052 AU
Legal Entity TypeCompany
Legal Entity State AU

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Nancy Sabarra
Fross Zelnick Lehrman & Zissu, P.C.
151 West 42nd St., 17th Fl.
New York NY 10036

Good, Services, and Codes

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:10
U.S. Codes:026,039,044
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0051Pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders; vaccines; blood products in this class, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood or bleeding disorders; test kits in the class, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, RhD reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or IgG subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies ; pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes

Trademark Filing History

DescriptionDateEvent Coding
SN ASSIGNED FOR SECT 66A APPL FROM IB2013-04-251 REPR M:
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2013-04-262 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2013-04-263 DOCK D:Assigned to Examiner
APPLICATION FILING RECEIPT MAILED2013-04-304 MAFR O:Outgoing Correspondence
NON-FINAL ACTION WRITTEN2013-05-025 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW2013-05-036 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU2013-05-037 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB2013-05-038 RFCS P:
REFUSAL PROCESSED BY IB2013-05-269 RFNT P:
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2013-10-1810 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2013-10-1811 ARAA I:Incoming Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2013-10-2412 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2013-10-2413 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2013-10-2414 TEME I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER2013-10-2515 CNSA O:Outgoing Correspondence
ASSIGNED TO LIE2013-11-1316 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED2013-11-1817 PREV O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2013-12-0418 NONP E:E-Mail
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB2013-12-0419 OP2R P:
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB2013-12-0420 OPNS P:
PUBLISHED FOR OPPOSITION2013-12-2421 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2013-12-2422 NPUB E:E-Mail
NOTIFICATION PROCESSED BY IB2013-12-2423 GPNX P:
REGISTERED-PRINCIPAL REGISTER2014-03-1124 R.PR A:Allowance for Publication
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB2014-06-1125 FICR P:
FINAL DISPOSITION PROCESSED2014-06-2326 FIMP P:
FINAL DISPOSITION NOTICE SENT TO IB2014-06-2327 FICS P:
FINAL DECISION TRANSACTION PROCESSED BY IB2014-07-2228 FINO P:
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2016-07-0129 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2016-07-0130 ARAA I:Incoming Correspondence
NEW REPRESENTATIVE AT IB RECEIVED2016-12-1631 NREP P:
NEW REPRESENTATIVE AT IB RECEIVED2017-02-1032 NREP P:
NEW REPRESENTATIVE AT IB RECEIVED2017-05-1833 NREP P:
NEW REPRESENTATIVE AT IB RECEIVED2017-07-2734 NREP P:
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2018-12-1735 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2018-12-1736 ARAA I:Incoming Correspondence
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED2019-03-1137 REM3 E:E-Mail
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2019-11-2538 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2019-11-2539 ARAA I:Incoming Correspondence
CANCELLED SECTION 712021-02-2640 C71T O:Outgoing Correspondence
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED2021-10-2641 INTR P:
INVALIDATION PROCESSED2022-02-1142 INPC P:
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB2022-02-1143 INTS P:
TOTAL INVALIDATION PROCESSED BY THE IB2022-03-0644 INNT P:
DEATH OF INTERNATIONAL REGISTRATION2023-07-0945 DETH P:
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED2023-07-0946 DENC E:E-Mail

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed